Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The study purpose is to test the hypothesis that Chronic Phase Chronic Myeloid Leukemia (CP-CML) patients with stable Complete Molecular Response (CMR) who discontinue Dasatinib treatment are able to maintain a sustained remission in the long-term, with undetectable or minimally detectable BCR-ABL residual disease.
Critère d'inclusion
- Chronic Phase Chronic Myeloid Leukemia